KPIs & Operating Metrics(New)
Adjusted Ebitda By SegmentAdjusted Ebitda By Segment AnnualAdjusted Ebitda Margin By Segment %Adjusted Ebitda Margin By Segment Annual %Average Pmpm By Product TypeAverage Pmpm Fees / Revenue Per Case By SegmentAverage Unique MembersAverage Unique Members AnnualAverage Yield Per CaseBreakdown Of AssetsContractual ObligationsCost Of RevenueDeferred RevenueEmployee StatisticsGross Margin %Gross ProfitIncome (Loss) Before Income Tax By RegionLives By Product TypeLives Managed By SegmentLives On Platform/ Cases During Period By SegmentNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total Revenue %OPEX SegregationProperty And Equipment, NetRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By End MarketRevenue By End Market %Revenue By End Market AnnualRevenue By End Market Annual %Revenue By Product TypeRevenue By Product Type %Revenue By Product Type AnnualRevenue By Product Type Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Total Cases ManagedTotal Lives ManagedTotal Lives On Platform
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Evolent Health (EVH) Cost Of Revenue (2023 - 2025)

Evolent Health has reported Cost of Revenue over the past 11 years, most recently at $371.5 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 34.93% year-over-year to $371.5 million; the TTM value through Dec 2025 reached $1.5 billion, down 32.51%, while the annual FY2025 figure was $1.5 billion, 32.51% down from the prior year.
  • Cost of Revenue for Q4 2025 was $371.5 million at Evolent Health, down from $379.8 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $570.8 million in Q4 2024 and troughed at $157.8 million in Q1 2021.
  • A 5-year average of $343.0 million and a median of $347.9 million in 2023 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: surged 82.01% in 2022 and later tumbled 36.34% in 2025.
  • Year by year, Cost of Revenue stood at $164.5 million in 2021, then surged by 82.01% to $299.4 million in 2022, then surged by 51.8% to $454.4 million in 2023, then rose by 25.62% to $570.8 million in 2024, then crashed by 34.93% to $371.5 million in 2025.
  • Business Quant data shows Cost of Revenue for EVH at $371.5 million in Q4 2025, $379.8 million in Q3 2025, and $343.9 million in Q2 2025.